Characteristics | Hyponatremia n = 32 | Nonhyponatremia n = 103 | P-Value |
---|---|---|---|
Serum sodium, mmol/L (mean ± SD) | 129.3 ± 4.3 | 139.0 ± 2.4 | < 0.001 |
Age, yrs. (mean ± SD) | 52.0 ± 9.8 | 50.5 ± 10.0 | 0.465 |
Male | 28 (87.5%) | 75 (72.8%) | 0.088 |
In-hospital days (M) | 8.3 (4–20) | 7.5 (1.8–23) | 0.546 |
Hypertension | 7 (21.9%) | 16 (15.5%) | 0.405 |
Epilepsy | 3 (9.4%) | 15 (14.6%) | 0.648 |
Dyslipidemia | 4 (12.5%) | 11 (9.7%) | 1.000 |
Cerebral infarction | 5 (15.6%) | 8 (7.8%) | 0.330 |
Pulmonary infection | 4 (12.5%) | 3 (3.0%) | 0.093 |
Paralysis of cranial nerves | 7 (21.9%) | 16 (15.5%) | 0.405 |
Nasopharyngeal carcinoma | 31 (96.9%) | 95 (92.2%) | 0.607 |
Glioma | 1 (3.1%) | 7 (6.8%) | 0.734 |
Oral cancer | 0 (0%) | 1 (1.0%) | 1.000 |
Baseline T1-weight gadolinium-contrast area (cm2)(mean ± SD) | 5.1 ± 2.3 | 5.3 ± 3.8 | 0.810 |
BaselineT2-weighted area (cm2) (mean ± SD) | 10.6 ± 5.5 | 10.4 ± 6.6 | 0.843 |